A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes

被引:100
作者
Schneider, TJ
Fischer, GM
Donohoe, TJ
Colarusso, TP
Rothstein, TL
机构
[1] Boston Univ, Med Ctr, Dept Microbiol, Boston, MA 02118 USA
[2] Boston Univ, Med Ctr, Dept Med, Boston, MA 02118 USA
[3] Boston Univ, Med Ctr, Evans Mem Dept Clin Res, Boston, MA 02118 USA
关键词
Fas; apoptosis; B lymphocytes; differential display; gene expression;
D O I
10.1084/jem.189.6.949
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The sensitivity of primary splenic B cells to Fas-mediated apoptosis is modulated in a receptor-specific fashion. Here we used a differential display strategy to detect cDNAs present in B cells rendered Fas resistant but absent in those rendered Fas sensitive. This led to the cloning and characterization of a novel 1.2-kb gene that encodes a Fas apoptosis inhibitory molecule (FAIM). faim-transfected BAL-17 B lymphoma cells were less sensitive by half or more to Fas-mediated apoptosis than were vector-transfected controls, using Fas ligand-bearing T cells or a cytotoxic anti-Fas antibody to trigger Fas, and this was associated with inhibition of Fas-induced poly-ADP ribose polymerase (PARP) cleavage. In primary B cells, the time course of faim mRNA and FAIM protein expression correlated with the induction of Fas resistance by surface (s)Ig engagement. Thus, FAIM is an inducible effector molecule that mediates Fas resistance produced by sig engagement in B cells. However, faim is broadly expressed in various tissues and the faim sequence is highly conserved evolutionarily, suggesting that its role extends beyond lymphocyte homeostasis. As FAIM has no significant regions of homology to other gene products that modulate Fas killing, it appears to represent a distinct, new class of antiapoptotic protein.
引用
收藏
页码:949 / 955
页数:7
相关论文
共 45 条
[1]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[2]  
CHILES TC, 1991, J IMMUNOL, V146, P1730
[3]  
CHINNAIYAN AM, 1995, CELL, V81, P502
[4]   ELECTROPORATION FOR THE EFFICIENT TRANSFECTION OF MAMMALIAN-CELLS WITH DNA [J].
CHU, G ;
HAYAKAWA, H ;
BERG, P .
NUCLEIC ACIDS RESEARCH, 1987, 15 (03) :1311-1326
[5]   Tolerant B lymphocytes acquire resistance to fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded [J].
Foote, LC ;
Marshak-Rothstein, A ;
Rothstein, TL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) :847-853
[6]  
Foote LC, 1996, J IMMUNOL, V157, P2749
[7]  
Foote LC, 1996, J IMMUNOL, V157, P1878
[8]   INDUCTION OF THE TRANSCRIPTION FACTORS NF-KB, AP-1 AND NF-AT DURING B-CELL STIMULATION THROUGH THE CD40 RECEPTOR [J].
FRANCIS, DA ;
KARRAS, JG ;
KE, XY ;
SEN, R ;
ROTHSTEIN, TL .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (02) :151-161
[9]   C-ELEGANS CELL-SURVIVAL GENE CED-9 ENCODES A FUNCTIONAL HOMOLOG OF THE MAMMALIAN PROTOONCOGENE BCL-2 [J].
HENGARTNER, MO ;
HORVITZ, HR .
CELL, 1994, 76 (04) :665-676
[10]  
HU W, 1997, J BIOL CHEM, V272, P17255